| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |